Correction for Rasmussen et al., “Virology—the path forward”

AUTHOR CORRECTION

Volume 98, no. 1, e01791-23, 2024, https://doi.org/10.1128/jvi.01791-23. Page 3, line 7: “elevating SARS-CoV-1 to a select agent in 2009” should read “elevating SARS-CoV-1 to a select agent in 2012.”

The CDC proposed adding SARS-CoV-1 to the Select Agent registry in a federal notice on 13 July 2009 (https://www.federalregister.gov/documents/2009/07/13/E9-16536/possession-use-and-transfer-of-select-agents-and-toxins-proposed-addition-of-sars-associated). This notice of proposed rulemaking explicitly states that compliance with the proposed amendment would require anyone possessing SARS-CoV-1 to obtain current or amended registration with the HHS Select Agent Program and acknowledged that registration is a time-consuming and potentially costly process. Contemporaneous sources demonstrate that the research impact was anticipated in 2009 (https://absa.org/wp-content/uploads/2017/01/090911DHHS_SARS_Select_Agent_Comments.pdf and https://www.cidrap.umn.edu/sars/cdc-proposes-list-sars-virus-select-agent) and had already had a negative impact on SARS-CoV-1 research (S. Matthews, Nat Med 18:1722, 2012, https://doi.org/10.1038/nm1212-1722 and https://www.cidrap.umn.edu/anthrax/changes-select-agent-rules-concern-public-health-labs) by the time its addition to the Select Agent registry went into effect on 4 December 2012 (https://www.federalregister.gov/documents/2012/10/05/2012-24389/possession-use-and-transfer-of-select-agents-and-toxins-biennial-review).